Dr. Haghani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Boston
Boston, MA 02114
Summary
- Dr. Leila Haghani is based in Boston, MA, and specializes as an MD/DO. She completed her medical education at Tehran University of Medical Sciences in 2020 and a fellowship at Memorial Sloan Kettering Cancer Center from 2022 to 2023. Dr. Haghani is currently a Postdoc Researcher at UMass Memorial Medical Center. Her research includes significant publications in drug delivery systems and spinal cord injury, with over 700 citations for her 2016 review on smart micro/nanoparticles. She has been recognized with the Global Embolization award from GEST in 2024.
Education & Training
- University of Massachusetts Medical SchoolBiomedical Research, Vascular and Interventional Radiology, 2024 - 2025
- Tehran University of Medical Sciences School of MedicineClass of 2021
Awards, Honors, & Recognition
- IO Essentials Scholarship Society of Interventional Oncology’s (SIO), 2025
- Global Embolization GEST, 2024
- Recognized for research excellence through an invitation to Sigma Xi Scientific Research Honor Society, 2024
- Join now to see all
Publications & Presentations
PubMed
- Practical Considerations When Choosing Chemoembolization versus Radioembolization for Hepatocellular Carcinoma.Ashkan Heshmatzadeh Behzadi, Leila Haghani, Donna L D'Souza, Siobhan Flanagan, Christopher Jones
Seminars in Interventional Radiology. 2024-02-01 - Immunotherapy and transarterial embolization in patients with metastatic melanoma: a retrospective cohort study.Leila Haghani, Chenyang Zhan, Hooman Yarmohammadi, Etay Ziv, Vlasios S Sotirchos
Immunotherapy. 2024-01-01 - 5 citationsAnti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options.Miles Pourbaghi, Leila Haghani, Ken Zhao, Anita Karimi, Brett Marinelli
Current Oncology. 2023-07-10
Books/Book Chapters
Abstracts/Posters
- Combination of Transarterial Radioembolization and Immunotherapy in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-AnalysisLeila Haghani, JVIR, Las Vegas
- Systematic Review and Meta-Analysis Of Comparing the Efficacy of TACE Plus Lenvatinib with and without PD-1 Inhibitors in Unresectable Hepatocellular CarcinomaLeila Haghani, JVIR, Nashville
Authored Content
- Unlocking the Potential of Targeted Cancer Therapy for Precision MedicineAugust 2024
Press Mentions
- Leila Haghani: Feeling inspired to push the boundaries of medical innovationAugust 8th, 2024
Grant Support
- Smart micro/ nanoparticles in Stimulus-Responsive Drug/Gene Delivery SystemsNIHPresent
Committees
- Postdoc Fellow, Society of Interventional Radiology 2022 - 2024
- SIO line SIRRFS, Society of Interventional Radiology (SIR), Awarded 320 points,
- Editorial board trainee, Radiology Society of North America (RSNA)
- Editorial Board Trainee, JVIR Journal
Professional Memberships
- Society of interventional radiology (SIR)Fellow
- Society of Interventional OncologyFellow
Other Languages
- Turkish, Dari, Urdu, Farsi, Tajik
External Links
- Google Scholarhttps://scholar.google.com/citations?user=dlIgE2cAAAAJ&hl=en
- LinkedInhttps://www.linkedin.com/in/leila-haghani-59a69448/
- RSNAhttps://pubs.rsna.org/page/imaging-cancer/teb
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: